We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALBO
2676
DELISTED
Albireo Pharma Inc
ALBO
$0 ﹤0.01%
+25
New +$590
AVYA
2677
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$0 ﹤0.01%
+47
New +$542
CEA
2678
DELISTED
China Eastern Airlines
CEA
$0 ﹤0.01%
+52
New +$970
PFXNL
2679
DELISTED
PhenixFIN Corporation 6.125% Senior Notes due 2023
PFXNL
-757
Closed -$18K
TEN
2680
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$0 ﹤0.01%
107
+95
+792% +$554
CTT
2681
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
-303
Closed -$3K
ACH
2682
DELISTED
Alum Corp of China Ltd
ACH
$0 ﹤0.01%
64
-62
-49% -$309
RDUS
2683
DELISTED
Radius Health, Inc.
RDUS
$0 ﹤0.01%
18
NPTN
2684
DELISTED
NEOPHOTONICS CORP
NPTN
$0 ﹤0.01%
+88
New +$759
WMC
2685
DELISTED
Western Asset Mortgage Capital Corporation
WMC
-35
Closed -$3K
COHR
2686
DELISTED
Coherent Inc
COHR
-6
Closed
TSC
2687
DELISTED
TriState Capital Holdings, Inc.
TSC
-147
Closed -$3K
SFUN
2688
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$0 ﹤0.01%
14
-6
-30% -$71
SRGA
2689
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-5
Closed
XENT
2690
DELISTED
Intersect ENT, Inc
XENT
$0 ﹤0.01%
38
-77
-67% -$896
HGH
2691
DELISTED
THE HARTFORD FINANCIAL SERVICES GROUP, INC. 7.875% FIXED-TO-FLOATING RATE JR SUB DEBENTURE DUE 2042
HGH
-12
Closed
RVI
2692
DELISTED
Retail Value Inc. Common Shares
RVI
$0 ﹤0.01%
54
RRD
2693
DELISTED
RR Donnelley & Sons Co.
RRD
-65
Closed
ODT
2694
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$0 ﹤0.01%
+23
New +$744
NEE.PRK
2695
DELISTED
NextEra Energy Capital Holdings, Inc. Series K Junior Subordinated Debentures due June 1, 2076
NEE.PRK
-2,000
Closed -$52K
XLRN
2696
DELISTED
Acceleron Pharma
XLRN
$0 ﹤0.01%
+10
New +$964
FLXN
2697
DELISTED
Flexion Therapeutics, Inc.
FLXN
-698
Closed -$14K
NNA
2698
DELISTED
Navios Maritime Acquisition Corporation
NNA
$0 ﹤0.01%
33
DUKH
2699
DELISTED
Duke Energy Corporation 5.125% Junior Subordinated Debentures due January 15, 2073
DUKH
-600
Closed -$15K
WFC.PRX
2700
DELISTED
Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu
WFC.PRX
-1,500
Closed -$39K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.